On the public citation graph

Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted 99mTc-Radioimaging Agents

0 signed · 204 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.298.13.1596openalex-snapshot
Grading of Prostate Cancer
inferredcites →https://doi.org/10.1002/(sici)1097-0045(19981101)37:3<140::aid-pros3>3.0.co;2-qopenalex-snapshot
Prostate cancer and prostate bed SPECT imaging with ProstaScint®: Semiquantitative correlation with prostatic biopsy results
inferredcites →https://doi.org/10.1002/(sici)1097-0142(19960815)78:4<809::aid-cncr18>3.0.co;2-zopenalex-snapshot
Evaluation and comparison of two new prostate carcinoma markers: Free-prostate specific antigen and prostate specific membrane antigen
inferredcites →https://doi.org/10.1002/cne.903150208openalex-snapshot
Immunocytochemical localization of the N‐acetyl‐aspartyl‐glutamate (NAAG) hydrolyzing enzyme N‐acetylated α‐linked acidic dipeptidase (NAALADase)
inferredcites →https://doi.org/10.1002/ijc.2910620511openalex-snapshot
Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluids
inferredcites →https://doi.org/10.1002/jcb.10661openalex-snapshot
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
inferredcites →https://doi.org/10.1016/0883-2897(89)90191-8openalex-snapshot
A simple qualitative determination of human antibodies to murine immunoglobulins (HAMA) in serum samples
inferredcites →https://doi.org/10.1016/j.bmc.2004.03.051openalex-snapshot
[11C]Choline as a PET biomarker for assessment of prostate cancer tumor models
inferredcites →https://doi.org/10.1016/j.crad.2007.05.022openalex-snapshot
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis
inferredcites →https://doi.org/10.1016/j.freeradbiomed.2007.03.031openalex-snapshot
Characterization of redox state of two human prostate carcinoma cell lines with different degrees of aggressiveness
inferredcites →https://doi.org/10.1016/s0022-5347(17)41192-xopenalex-snapshot
Assessment of Screening for Prostate Cancer Using the Digital Rectal Examination
inferredcites →https://doi.org/10.1016/s0090-4295(01)00983-9openalex-snapshot
Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma
inferredcites →https://doi.org/10.1016/s0090-4295(96)00184-7openalex-snapshot
Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy
inferredcites →https://doi.org/10.1016/s0090-4295(98)00278-7openalex-snapshot
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases
inferredcites →https://doi.org/10.1016/s0167-4781(98)00200-0openalex-snapshot
Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene
inferredcites →https://doi.org/10.1016/s1470-2045(06)70981-0openalex-snapshot
Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial
inferredcites →https://doi.org/10.1021/bc000070vopenalex-snapshot
Bifunctional Chelators for Therapeutic Lanthanide Radiopharmaceuticals
inferredcites →https://doi.org/10.1021/bc020034ropenalex-snapshot
Radiochemical Investigations of 99mTc−N3S-X-BBN[7−14]NH2: An in Vitro/in Vivo Structure−Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon Tethering Moieties
inferredcites →https://doi.org/10.1021/bc0200430openalex-snapshot
Synthesis and Biological Evaluation of EC20: A New Folate-Derived, 99mTc-Based Radiopharmaceutical
inferredcites →https://doi.org/10.1021/cr980436lopenalex-snapshot
99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals
inferredcites →https://doi.org/10.1021/ja9621760openalex-snapshot
Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids
inferredcites →https://doi.org/10.1021/jm000406mopenalex-snapshot
Design of Remarkably Simple, Yet Potent Urea-Based Inhibitors of Glutamate Carboxypeptidase II (NAALADase)
inferredcites →https://doi.org/10.1021/jm0306430openalex-snapshot
Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy
inferredcites →https://doi.org/10.1021/jm030644sopenalex-snapshot
Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening
inferredcites →https://doi.org/10.1021/jm800111uopenalex-snapshot
Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)
inferredcites →https://doi.org/10.1021/jm801055hopenalex-snapshot
Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer
inferredcites →https://doi.org/10.1021/mp900069dopenalex-snapshot
Prostate-Specific Membrane Antigen Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing Ligand
inferredcites →https://doi.org/10.1038/nrd1903openalex-snapshot
NAAG peptidase inhibitors and their potential for diagnosis and therapy
inferredcites →https://doi.org/10.1038/sj.emboj.7600969openalex-snapshot
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer
inferredcites →https://doi.org/10.1038/sj.pcan.4500570openalex-snapshot
Evaluation of preoperative ProstaScint™ scans in the prediction of nodal disease
inferredcites →https://doi.org/10.1073/pnas.93.2.749openalex-snapshot
Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase.
inferredcites →https://doi.org/10.1093/jnci/82.14.1191openalex-snapshot
In Vivo Tumor Targeting of a Recombinant Single-Chain Antigen-Binding Protein
inferredcites →https://doi.org/10.1093/jnci/90.12.925openalex-snapshot
Short-Term Effects of Population-Based Screening for Prostate Cancer on Health-Related Quality of Life
inferredcites →https://doi.org/10.1146/annurev.bioeng.9.060906.152025openalex-snapshot
Nanotechnology Applications in Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-07-1517openalex-snapshot
N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl- l -Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer
inferredcites →https://doi.org/10.1200/jco.2004.09.154openalex-snapshot
Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer
inferredcites →https://doi.org/10.1200/jco.2006.07.8097openalex-snapshot
Vascular Targeted Therapy With Anti–Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors
inferredcites →https://doi.org/10.1615/critrevimmunol.v21.i1-3.160openalex-snapshot
A Unique Folate Hydrolase, Prostate-Specific Membrane Antigen (PSMA): A Target For Immunotherapy?
inferredcites →https://doi.org/10.2174/0929867013372797openalex-snapshot
Design of NAALADase Inhibitors A Novel Neuroprotective Strategy
inferredcites →https://doi.org/10.3322/ca.2007.0010openalex-snapshot
Cancer Statistics, 2008

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4996194openalex-extracted
Synthesis and Study of Hynic Conjugated Psma Targeting Ligands for Prostate Cancer Diagnosis
inferred← citeshttps://doi.org/10.1002/9781118833322.ch19openalex-snapshot
Receptor‐Mediated Drug Delivery
inferred← citeshttps://doi.org/10.1002/9783527827855.ch11openalex-snapshot
Metal Complexes as the Means or the End of Targeted Delivery for Unmet Needs
inferred← citeshttps://doi.org/10.1002/ajoc.201900329openalex-snapshot
Prostate‐Specific Membrane Antigen (PSMA)‐Targeted Radionuclide Probes for Imaging and Therapy of Prostate Cancer
inferred← citeshttps://doi.org/10.1002/ange.201204631openalex-snapshot
Entwicklung zielgerichteter niedermolekularer zytotoxischer Wirkstoffverbindungen mit DNA‐codierten chemischen Bibliotheken
inferred← citeshttps://doi.org/10.1002/ange.201908964openalex-snapshot
A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and Retention
inferred← citeshttps://doi.org/10.1002/anie.201204631openalex-snapshot
Small Targeted Cytotoxics: Current State and Promises from DNA‐Encoded Chemical Libraries
inferred← citeshttps://doi.org/10.1002/anie.201908964openalex-snapshot
A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and Retention
inferred← citeshttps://doi.org/10.1002/cbic.202000577openalex-snapshot
Fc‐Binding Antibody‐Recruiting Molecules Targeting Prostate‐Specific Membrane Antigen: Defucosylation of Antibody for Efficacy Improvement**
inferred← citeshttps://doi.org/10.1002/cnr2.1169openalex-snapshot
Comparison of prostate‐specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer
inferred← citeshttps://doi.org/10.1002/cpch.50openalex-snapshot
Preparation of Ligand‐Targeted Drug Conjugates for Cancer Therapy and Their Evaluation In Vitro
inferred← citeshttps://doi.org/10.1002/cpz1.199openalex-snapshot
Agarose Micro‐Well Platform for Rapid Generation of Homogenous 3D Tumor Spheroids
inferred← citeshttps://doi.org/10.1002/cpz1.623openalex-snapshot
In Vitro and In Vivo Evaluation of Targeted Fluorescent Imaging Agents for Diagnosis and Resection of Cancer
inferred← citeshttps://doi.org/10.1002/jgm.1495openalex-snapshot
Transcriptional regulation of inducible nitric oxide synthase gene therapy: targeting early stage and advanced prostate cancer
inferred← citeshttps://doi.org/10.1002/jlcr.2944openalex-snapshot
One pot radiofluorination of a new potential PSMA ligand [Al18F]NOTA‐DUPA‐Pep
inferred← citeshttps://doi.org/10.1002/med.21387openalex-snapshot
Small Molecules for Active Targeting in Cancer
inferred← citeshttps://doi.org/10.1002/med.21508openalex-snapshot
Targeting prostate cancer: Prostate‐specific membrane antigen based diagnosis and therapy
inferred← citeshttps://doi.org/10.1002/pros.21413openalex-snapshot
Imaging prostate cancer lymph node metastases with a multimodality contrast agent
inferred← citeshttps://doi.org/10.1002/pros.22789openalex-snapshot
Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker
inferred← citeshttps://doi.org/10.1007/978-3-319-16304-8_14openalex-snapshot
Genitourinary System Tumors
inferred← citeshttps://doi.org/10.1007/978-3-319-40070-9_4openalex-snapshot
Chemistry of PET Radiopharmaceuticals: Labelling Strategies
inferred← citeshttps://doi.org/10.1007/s00117-014-2792-6openalex-snapshot
68Ga-PSMA als neuer Tracer für die Evaluation des Prostatakarzinoms
inferred← citeshttps://doi.org/10.1007/s00259-013-2374-2openalex-snapshot
PSMA as a target for radiolabelled small molecules
inferred← citeshttps://doi.org/10.1007/s00259-013-2660-zopenalex-snapshot
Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience
inferred← citeshttps://doi.org/10.1007/s10967-012-2293-xopenalex-snapshot
Radiosynthesis of [18F]FEt-Tyr-urea-Glu ([18F]FEtTUG) as a new PSMA ligand
inferred← citeshttps://doi.org/10.1007/s11094-019-01994-1openalex-snapshot
Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs
inferred← citeshttps://doi.org/10.1007/s11307-015-0844-6openalex-snapshot
Radiofluorination of PSMA-HBED via Al18F2+ Chelation and Biological Evaluations In Vitro
inferred← citeshttps://doi.org/10.1007/s11307-025-02052-xopenalex-snapshot
Detection of Prostate Cancer Metastases During Pelvic Lymph Node Dissection with the PSMA-Targeted Fluorescent Agent OTL78: A Phase II Study
inferred← citeshttps://doi.org/10.1007/s13139-025-00963-9openalex-snapshot
Current Status and Advancements in Radiotheranostics and Targeted Radionuclide Therapy in Malaysia
inferred← citeshttps://doi.org/10.1007/s44211-024-00514-wopenalex-snapshot
Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranostics
inferred← citeshttps://doi.org/10.1016/b978-0-323-85650-8.00010-3openalex-snapshot
Revolutionizing medical diagnosis with SPECT imaging: Clinical applications of a nuclear imaging technology
inferred← citeshttps://doi.org/10.1016/j.actbio.2020.06.019openalex-snapshot
Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy
inferred← citeshttps://doi.org/10.1016/j.apradiso.2011.03.041openalex-snapshot
Radiosynthesis of a new PSMA targeting ligand ([18F]FPy-DUPA-Pep)
inferred← citeshttps://doi.org/10.1016/j.bbadis.2013.04.028openalex-snapshot
Mutation at the folate receptor 4 locus modulates gene expression profiles in the mouse uterus in response to periconceptional folate supplementation
inferred← citeshttps://doi.org/10.1016/j.bbrc.2009.10.017openalex-snapshot
A low molecular weight PSMA-based fluorescent imaging agent for cancer
inferred← citeshttps://doi.org/10.1016/j.bioorg.2019.103154openalex-snapshot
Tyrosine-based asymmetric urea ligand for prostate carcinoma: Tuning biological efficacy through in silico studies
inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.103743openalex-snapshot
Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen
inferred← citeshttps://doi.org/10.1016/j.bioorg.2025.108130openalex-snapshot
Design, synthesis, and biological evaluation of novel thiourea derivatives as small molecule inhibitors for prostate specific membrane antigen
inferred← citeshttps://doi.org/10.1016/j.bioorg.2026.110122openalex-snapshot
Structure–property relationships of benzyl-substituted urea-based ligands with Phe-Phe linker targeting prostate-specific membrane antigen labeled with gallium-68
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.09.057openalex-snapshot
A targeted low molecular weight near-infrared fluorescent probe for prostate cancer
inferred← citeshttps://doi.org/10.1016/j.bmcl.2012.09.014openalex-snapshot
Synthesis and SAR of 99mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates
inferred← citeshttps://doi.org/10.1016/j.bmcl.2017.09.065openalex-snapshot
PSMA-targeted bispecific Fab conjugates that engage T cells
inferred← citeshttps://doi.org/10.1016/j.bmcl.2021.128044openalex-snapshot
Dipeptide inhibitors of the prostate specific membrane antigen (PSMA): A comparison of urea and thiourea derivatives
inferred← citeshttps://doi.org/10.1016/j.bmcl.2022.128840openalex-snapshot
Synthesis and initial in vitro evaluation of PSMA-targeting ligands with a modified aromatic moiety at the lysine ε-nitrogen atom
inferred← citeshttps://doi.org/10.1016/j.ccr.2018.12.005openalex-snapshot
Radiotheranostics with radiolanthanides: Design, development strategies, and medical applications
inferred← citeshttps://doi.org/10.1016/j.crad.2010.03.011openalex-snapshot
Molecular imaging: current status and emerging strategies
inferred← citeshttps://doi.org/10.1016/j.drudis.2024.104130openalex-snapshot
Advances in structure-based drug design targeting membrane protein markers in prostate cancer
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113936openalex-snapshot
PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation
inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.118433openalex-snapshot
A series of conjugates based on prostate-specific membrane antigen ligands with the chelating agent DOTA: synthesis, radiolabeling, and biological activity
inferred← citeshttps://doi.org/10.1016/j.mencom.2020.11.022openalex-snapshot
Influence of the dipeptide linker configuration on the activity of PSMA ligands
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2014.01.001openalex-snapshot
Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2016.08.006openalex-snapshot
Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2017.01.010openalex-snapshot
99m Tc-labeling and evaluation of a HYNIC modified small-molecular inhibitor of prostate-specific membrane antigen
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2017.01.012openalex-snapshot
Clinical translation of a PSMA inhibitor for 99m Tc-based SPECT
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2017.05.005openalex-snapshot
99mTc-labeled PSMA inhibitor: Biokinetics and radiation dosimetry in healthy subjects and imaging of prostate cancer tumors in patients
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2021.01.002openalex-snapshot
Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer
inferred← citeshttps://doi.org/10.1016/j.omtn.2024.102193openalex-snapshot
Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent
inferred← citeshttps://doi.org/10.1016/j.pscia.2024.100048openalex-snapshot
Targeted drug conjugates in cancer therapy: Challenges and opportunities
inferred← citeshttps://doi.org/10.1016/j.rechem.2021.100240openalex-snapshot
Design and synthesis of a new conjugate of a tris(3-hydroxy-4-pyridinone) chelator (KC18) for potential use as gallium-68-labeled prostate-specific membrane antigen (PSMA) radiopharmaceutical
inferred← citeshttps://doi.org/10.1021/acs.analchem.7b02016openalex-snapshot
Near-Infrared Neodymium Tag for Quantifying Targeted Biomarker and Counting Its Host Circulating Tumor Cells
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.5b00679openalex-snapshot
Preclinical Comparative Study of 68Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.9b00758openalex-snapshot
Image-Guided Surgery: Are We Getting the Most Out of Small-Molecule Prostate-Specific-Membrane-Antigen-Targeted Tracers?
inferred← citeshttps://doi.org/10.1021/acs.chemrev.7b00013openalex-snapshot
Ligand-Targeted Drug Delivery
inferred← citeshttps://doi.org/10.1021/acs.inorgchem.0c00509openalex-snapshot
Chelation in One Fell Swoop: Optimizing Ligands for Smaller Radiometal Ions
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c00291openalex-snapshot
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c01935openalex-snapshot
Synthesis and Biological Evaluation of PSMA Ligands with Aromatic Residues and Fluorescent Conjugates Based on Them
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00003openalex-snapshot
Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c01491openalex-snapshot
Design and Synthesis of Indenoisoquinolines Targeting Topoisomerase I and Other Biological Macromolecules for Cancer Chemotherapy
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c02626openalex-snapshot
Prodrugs Targeting Prostate-Specific Membrane Antigen against Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c02767openalex-snapshot
Development of [ 99m Tc]TcO-ABX474: Design, Synthesis, and Biological Evaluation of PSMA-Binding Technetium-99m Radioligands for SPECT Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01268openalex-snapshot
[ 18 F]Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA)
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b02022openalex-snapshot
Novel β- and γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.5c01804openalex-snapshot
SPECT Imaging with Bifunctional Technetium-99m Nitrido Bis(thiosemicarbazonato) Complexes Tethered to Inhibitors of the Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1021/acsptsci.3c00146openalex-snapshot
The Preparation and Execution of Exploratory Human Studies on Novel 99mTc-Labeled Glucosamine Derivatives Containing Different Phenyl Isonitriles as Promising Tumor Imaging Agents
inferred← citeshttps://doi.org/10.1021/acssensors.7b00544openalex-snapshot
PLK1-Targeted Fluorescent Tumor Imaging with High Signal-to-Background Ratio
inferred← citeshttps://doi.org/10.1021/bc200279bopenalex-snapshot
68 Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
inferred← citeshttps://doi.org/10.1021/bc400131aopenalex-snapshot
Development of Tumor-Targeted Near Infrared Probes for Fluorescence Guided Surgery
inferred← citeshttps://doi.org/10.1021/ja104591mopenalex-snapshot
A Remote Arene-Binding Site on Prostate Specific Membrane Antigen Revealed by Antibody-Recruiting Small Molecules
inferred← citeshttps://doi.org/10.1021/jacs.1c04264openalex-snapshot
Multiplex and In Vivo Optical Imaging of Discrete Luminescent Lanthanide Complexes Enabled by In Situ Cherenkov Radiation Mediated Energy Transfer
inferred← citeshttps://doi.org/10.1021/jm100623eopenalex-snapshot
68 Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
inferred← citeshttps://doi.org/10.1021/jm100729bopenalex-snapshot
Synthesis and Biological Analysis of Prostate-Specific Membrane Antigen-Targeted Anticancer Prodrugs
inferred← citeshttps://doi.org/10.1021/jm400823wopenalex-snapshot
Effect of Chelators on the Pharmacokinetics of 99mTc-Labeled Imaging Agents for the Prostate-Specific Membrane Antigen (PSMA)
inferred← citeshttps://doi.org/10.1021/jm400895sopenalex-snapshot
Preparation of Asymmetric Urea Derivatives that Target Prostate-Specific Membrane Antigen for SPECT Imaging
inferred← citeshttps://doi.org/10.1021/jm401921jopenalex-snapshot
64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.1021/jm5018384openalex-snapshot
DUPA Conjugation of a Cytotoxic Indenoisoquinoline Topoisomerase I Inhibitor for Selective Prostate Cancer Cell Targeting
inferred← citeshttps://doi.org/10.1038/nrd4519openalex-snapshot
Principles in the design of ligand-targeted cancer therapeutics and imaging agents
inferred← citeshttps://doi.org/10.1038/nrurol.2016.26openalex-snapshot
Current use of PSMA–PET in prostate cancer management
inferred← citeshttps://doi.org/10.1038/pcan.2017.23openalex-snapshot
Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1039/c4py00999aopenalex-snapshot
Development of a polymer theranostic for prostate cancer
inferred← citeshttps://doi.org/10.1039/c9cc07009eopenalex-snapshot
Monoamine oxidase-A targeting probe for prostate cancer imaging and inhibition of metastasis
inferred← citeshttps://doi.org/10.1039/c9md00279kopenalex-snapshot
A small molecule drug conjugate (SMDC) of DUPA and a duocarmycin built on the solid phase
inferred← citeshttps://doi.org/10.1039/d0bm01970dopenalex-snapshot
A targeted near-infrared nanoprobe for deep-tissue penetration and imaging of prostate cancer
inferred← citeshttps://doi.org/10.1042/bst20253010openalex-snapshot
Redesigning miR-34a: structural and chemical advances in the therapeutic development of an miRNA anti-cancer agent
inferred← citeshttps://doi.org/10.1053/j.seminoncol.2010.11.010openalex-snapshot
The Evolution of Imaging in Cancer: Current State and Future Challenges
inferred← citeshttps://doi.org/10.1055/a-0671-5458openalex-snapshot
99mTc-PSMA Radioliganden für die SPECT Bildgebung von Prostatakrebs – Eine Alternative zu PET?
inferred← citeshttps://doi.org/10.1055/s-0045-1809921openalex-snapshot
A New Labeling Method of 99mTc-PSMA-HBED-CC
inferred← citeshttps://doi.org/10.1073/pnas.1714587115openalex-snapshot
PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice
inferred← citeshttps://doi.org/10.1080/07391102.2021.1936642openalex-snapshot
Imaging of prostate cancer: optimizing affinity to prostate specific membrane antigen by spacer modifications in a tumor spheroid model
inferred← citeshttps://doi.org/10.1088/0031-9155/61/11/4300openalex-snapshot
Similarity-regulation of OS-EM for accelerated SPECT reconstruction
inferred← citeshttps://doi.org/10.1089/cbr.2023.0024openalex-snapshot
Synthesis and Radiolabeling of Glu-Urea-Lys with 99m Tc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor
inferred← citeshttps://doi.org/10.1093/carcin/bgx141openalex-snapshot
Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities
inferred← citeshttps://doi.org/10.1093/narcan/zcab030openalex-snapshot
Ligand-mediated delivery of RNAi-based therapeutics for the treatment of oncological diseases
inferred← citeshttps://doi.org/10.1097/mnm.0000000000002075openalex-snapshot
Intraindividual comparison of 99mTc-HYNIC-PSMA-11 and 99mTc-MDP bone scan with SPECT/CT for detecting skeletal metastases in prostate cancer: a prospective concordance study
inferred← citeshttps://doi.org/10.1101/2024.10.31.621442openalex-snapshot
A New Labelling Method of 99m Tc-PSMA-HBED-CC
inferred← citeshttps://doi.org/10.1109/nssmic.2012.6551755openalex-snapshot
Count-Regulated OSEM reconstruction
inferred← citeshttps://doi.org/10.1109/tmi.2013.2279851openalex-snapshot
Fast Count-Regulated OSEM Reconstruction With Adaptive Resolution Recovery
inferred← citeshttps://doi.org/10.1111/j.1749-6632.2009.04977.xopenalex-snapshot
Ligand‐Targeted Delivery of Small Interfering RNAs to Malignant Cells and Tissues
inferred← citeshttps://doi.org/10.1111/jcmm.15350openalex-snapshot
Prostate‐specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain
inferred← citeshttps://doi.org/10.1126/scitranslmed.3003886openalex-snapshot
Engineering a Prostate-Specific Membrane Antigen–Activated Tumor Endothelial Cell Prodrug for Cancer Therapy
inferred← citeshttps://doi.org/10.1158/0008-5472.can-09-1682openalex-snapshot
Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-11-1357openalex-snapshot
2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-18-0803openalex-snapshot
Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted Near-Infrared Imaging Agent for Fluorescence-Guided Surgery of Prostate Cancer
inferred← citeshttps://doi.org/10.1177/1536012117737010openalex-snapshot
Radiochemistry and Preclinical PET Imaging of 68 Ga-Desferrioxamine Radiotracers Targeting Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1186/2191-219x-2-23openalex-snapshot
A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer
inferred← citeshttps://doi.org/10.1186/s12894-017-0203-9openalex-snapshot
Anti-tumor effects of a recombinant anti-prostate specific membrane antigen immunotoxin against prostate cancer cells
inferred← citeshttps://doi.org/10.1186/s13550-014-0063-1openalex-snapshot
Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer
inferred← citeshttps://doi.org/10.1186/s13550-018-0382-8openalex-snapshot
Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007
inferred← citeshttps://doi.org/10.1186/s41181-021-00124-1openalex-snapshot
Design of PSMA ligands with modifications at the inhibitor part: an approach to reduce the salivary gland uptake of radiolabeled PSMA inhibitors?
inferred← citeshttps://doi.org/10.1371/journal.pone.0145755openalex-snapshot
(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors
inferred← citeshttps://doi.org/10.1515/ract-2025-0038openalex-snapshot
Synthesis and radiolabelling studies of hynic conjugated PSMA targeting ligands
inferred← citeshttps://doi.org/10.15690/vramn2207openalex-snapshot
99mTc-Labelled Low Molecular Weight Inhibitors of Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1586/erm.09.73openalex-snapshot
Putative molecular signatures for the imaging of prostate cancer
inferred← citeshttps://doi.org/10.18632/oncotarget.15733openalex-snapshot
PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responses
inferred← citeshttps://doi.org/10.18632/oncotarget.415openalex-snapshot
A Modular Strategy to Prepare Multivalent Inhibitors of Prostate-Specific Membrane Antigen (PSMA)
inferred← citeshttps://doi.org/10.2174/092986712799034888openalex-snapshot
Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
inferred← citeshttps://doi.org/10.2174/092986712799462612openalex-snapshot
GCPII Imaging and Cancer
inferred← citeshttps://doi.org/10.2174/0929867327666201006153847openalex-snapshot
Evolution of Peptide-Based Prostate-Specific Membrane Antigen (PSMA) Inhibitors: An Approach to Novel Prostate Cancer Therapeutics
inferred← citeshttps://doi.org/10.2174/1568026611313080008openalex-snapshot
PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.2174/1568026619666190201100739openalex-snapshot
Recent Advances in Prostate-Specific Membrane Antigen-Based Radiopharmaceuticals
inferred← citeshttps://doi.org/10.2174/1573405615666190225155254openalex-snapshot
Comparison of Bone Uptake in Bone Scan and Ga-68 PSMA PET/CT Images in Patients with Prostate Cancer
inferred← citeshttps://doi.org/10.2174/1874471012666190729151540openalex-snapshot
Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications
inferred← citeshttps://doi.org/10.2217/clp.14.27openalex-snapshot
Development and clinical applications of siRNA-encapsulated lipid nanoparticles in cancer
inferred← citeshttps://doi.org/10.2967/jnumed.109.061838openalex-snapshot
New Agents and Techniques for Imaging Prostate Cancer
inferred← citeshttps://doi.org/10.2967/jnumed.112.111203openalex-snapshot
First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer
inferred← citeshttps://doi.org/10.2967/jnumed.112.116624openalex-snapshot
99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.2967/jnumed.114.144998openalex-snapshot
Evaluation of a Nonpeptidic Ligand for Imaging of Cholecystokinin 2 Receptor–Expressing Cancers
inferred← citeshttps://doi.org/10.2967/jnumed.115.158550openalex-snapshot
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
inferred← citeshttps://doi.org/10.2967/jnumed.115.164442openalex-snapshot
68Ga-PSMA-HBED-CC PET for Differential Diagnosis of Suggestive Lung Lesions in Patients with Prostate Cancer
inferred← citeshttps://doi.org/10.3109/1061186x.2016.1154564openalex-snapshot
Small-molecule PSMA ligands. Current state, SAR and perspectives
inferred← citeshttps://doi.org/10.33590/emjurol/10312763openalex-snapshot
PSMA-Specific Ligands in Prostate Cancer Diagnosis and Therapy
inferred← citeshttps://doi.org/10.3389/fchem.2018.00107openalex-snapshot
Synthesis of Symmetrical Tetrameric Conjugates of the Radiolanthanide Chelator DOTPI for Application in Endoradiotherapy by Means of Click Chemistry
inferred← citeshttps://doi.org/10.3389/fchem.2022.898692openalex-snapshot
Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617
inferred← citeshttps://doi.org/10.3389/fonc.2018.00653openalex-snapshot
New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.3389/fonc.2021.758143openalex-snapshot
Advanced Nano-Carriers for Anti-Tumor Drug Loading
inferred← citeshttps://doi.org/10.3390/cancers11091371openalex-snapshot
Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.3390/ijms241512206openalex-snapshot
Synthesis, 123I-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures
inferred← citeshttps://doi.org/10.3390/ijms27104642openalex-snapshot
A Review of Approaches to the Synthesis of DCL-Based Prostate-Specific Membrane Antigen Ligands
inferred← citeshttps://doi.org/10.3390/inorganics8010005openalex-snapshot
Synthesis and Evaluation of 99mTc-Tricabonyl Labeled Isonitrile Conjugates for Prostate-Specific Membrane Antigen (PSMA) Image
inferred← citeshttps://doi.org/10.3390/molecules22040523openalex-snapshot
Metal-Based PSMA Radioligands
inferred← citeshttps://doi.org/10.3390/molecules27092617openalex-snapshot
A Review on the Current State and Future Perspectives of [99mTc]Tc-Housed PSMA-i in Prostate Cancer
inferred← citeshttps://doi.org/10.3390/molecules27217216openalex-snapshot
[99mTc]Tc-PSMA-T4—Novel SPECT Tracer for Metastatic PCa: From Bench to Clinic
inferred← citeshttps://doi.org/10.3390/molecules28072884openalex-snapshot
Targeting Carbohydrate Mimetics of Tetrahydrofuran-Containing Acetogenins to Prostate Cancer
inferred← citeshttps://doi.org/10.3390/molecules28104022openalex-snapshot
Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.3390/ph14111107openalex-snapshot
Initial Experience of Clinical Use of [99mTc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study
inferred← citeshttps://doi.org/10.3390/ph15050597openalex-snapshot
Fluorine-18 Labeled Urea-Based Ligands Targeting Prostate-Specific Membrane Antigen (PSMA) with Increased Tumor and Decreased Renal Uptake
inferred← citeshttps://doi.org/10.3390/ph7070779openalex-snapshot
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.3762/bjoc.14.244openalex-snapshot
Novel solid-phase strategy for the synthesis of ligand-targeted fluorescent-labelled chelating peptide conjugates as a theranostic tool for cancer
inferred← citeshttps://doi.org/10.3892/ijo.2014.2256openalex-snapshot
Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells
inferred← citeshttps://doi.org/10.6084/m9.figshare.14129120openalex-snapshot
Additional file 1 of Design of PSMA ligands with modifications at the inhibitor part: an approach to reduce the salivary gland uptake of radiolabeled PSMA inhibitors?
inferred← citeshttps://doi.org/10.64898/2026.04.10.717693openalex-snapshot
Comparative Study of Photodynamic and Sonodynamic Therapy Using a PSMA-Targeted Up-conversion Nanoplatform for Castration-Resistant Prostate Cancer
inferred← citeshttps://doi.org/10.70675/90d554f3z247fz414fzb972z3e282901963fopenalex-snapshot
Synthèse de prodrogues bispécifiques activables en milieu hypoxique : application au traitement du chondrosarcome et nouvelles perspectives dans le cadre du cancer de la prostate
inferred← citeshttps://doi.org/10.70675/ba007a31z10a7z43dez94faz4667fd54fdceopenalex-snapshot
Multifunctional platforms for cancer theranosis
inferred← citeshttps://doi.org/10.70675/ff7dcc7dzaeecz4574z851bzb468baa1e15bopenalex-snapshot
Synthese et evaluation de traceurs peptidiques heterobivalents pour l’imagerie moleculaire
inferred← citeshttps://doi.org/10.71267/mencom.7583openalex-snapshot
Fluorescent conjugates of PSMA-targeting ligand with cyanine dyes: synthetic approaches and photochemical properties
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.